Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 49.06% is 244% above its 5-year average of -34.07%, near the high end of its 5-year range (-363.87%–158.45%).
101.91% above its 12-month average of 24.30%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 158.45%.
NET PROFIT MARGIN
49.06%
NET PROFIT MARGIN AVG TTM
24.30%
NET PROFIT MARGIN AVG 3Y
-36.75%
NET PROFIT MARGIN AVG 5Y
-34.07%
NET PROFIT MARGIN AVG 10Y
-30.10%
NET PROFIT MARGIN AVG 15Y
-35.90%
NET PROFIT MARGIN AVG 20Y
-54.99%
CURRENT VS TTM AVG
+101.91%
CURRENT VS 3Y AVG
+233.48%
CURRENT VS 5Y AVG
+243.99%
CURRENT VS 10Y AVG
+262.99%
CURRENT VS 15Y AVG
+236.67%
CURRENT VS 20Y AVG
+189.22%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BioLife Solutions, Inc.
Market Cap
$1.89B
Net Profit Margin
49.06%
TTM Avg
24.30%
3Y Avg
-36.75%
5Y Avg
-34.07%
Market Cap
$1.87B
Net Profit Margin
-418.24%
TTM Avg
540.96%
3Y Avg
-464.63%
5Y Avg
-309.76%
Market Cap
$1.83B
Net Profit Margin
1.05%
TTM Avg
1.42%
3Y Avg
2.79%
5Y Avg
2.28%
Market Cap
$1.95B
Net Profit Margin
-7756.37%
TTM Avg
-3193.87%
3Y Avg
-2536.69%
5Y Avg
-2093.05%
Market Cap
$1.96B
Net Profit Margin
-15.82%
TTM Avg
-37.57%
3Y Avg
-42.30%
5Y Avg
-41.11%
Market Cap
$1.97B
Net Profit Margin
-20.02%
TTM Avg
-19.08%
3Y Avg
-29.38%
5Y Avg
-13.21%
Market Cap
$1.78B
Net Profit Margin
-636.99%
TTM Avg
-743.17%
3Y Avg
-743.17%
5Y Avg
-743.17%
Market Cap
$1.78B
Net Profit Margin
-672.16%
TTM Avg
-753.31%
3Y Avg
-935.73%
5Y Avg
-797.48%
Market Cap
$2.00B
Net Profit Margin
-13.36%
TTM Avg
-6.14%
3Y Avg
-11.71%
5Y Avg
-14.87%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioLife Solutions, Inc. (BLFS) | $1.89B | 49.06% | 24.30% | -36.75% | -34.07% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -418.24% | 540.96% | -464.63% | -309.76% |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.05% | 1.42% | 2.79% | 2.28% |
| Absci Corporation (ABSI)vs › | $1.95B | -7756.37% | -3193.87% | -2536.69% | -2093.05% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -15.82% | -37.57% | -42.30% | -41.11% |
| Azenta, Inc. (AZTA)vs › | $1.97B | -20.02% | -19.08% | -29.38% | -13.21% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -636.99% | -743.17% | -743.17% | -743.17% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -672.16% | -753.31% | -935.73% | -797.48% |
| AxoGen, Inc. (AXGN)vs › | $2.00B | -13.36% | -6.14% | -11.71% | -14.87% |
| Fortrea Holdings Inc. (FTRE)vs › | $2.01B | -3.18% | -24.20% | -10.68% | -8.90% |
Operating Margin
-1.1%
Net Profit Margin
49.1%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 158.45% |
| 2026-03-31 | 4.31% |
| 2025-12-31 | 18.82% |
| 2025-09-30 | 2.21% |
| 2025-06-30 | -62.30% |
| 2025-03-31 | -1.87% |
| 2024-12-31 | -363.87% |
| 2024-09-30 | -5.57% |
| 2024-06-30 | -105.09% |
| 2024-03-31 | -55.45% |
| 2023-12-31 | -40.88% |
| 2023-09-30 | -123.58% |
| 2023-06-30 | -34.88% |
| 2023-03-31 | -36.37% |
| 2022-12-31 | -113.49% |
| 2022-09-30 | -25.32% |
| 2022-06-30 | -179.80% |
| 2022-03-31 | -20.49% |
| 2021-12-31 | -38.79% |
| 2021-09-30 | 0.23% |
| 2021-06-30 | 25.24% |
| 2021-03-31 | -6.64% |
| 2020-12-31 | -14.45% |
| 2020-09-30 | -10.05% |
| 2020-06-30 | -165.12% |
| 2020-03-31 | 183.42% |
| 2019-12-31 | -147.53% |
| 2019-09-30 | 155.50% |
| 2019-06-30 | 63.45% |
| 2019-03-31 | -332.08% |
| 2018-12-31 | 16.37% |
| 2018-09-30 | 23.25% |
| 2018-06-30 | 22.00% |
| 2018-03-31 | 0.08% |
| 2017-12-31 | -17.80% |
| 2017-09-30 | -10.76% |
| 2017-06-30 | -30.03% |
| 2017-03-31 | -36.78% |
| 2016-12-31 | -147.73% |
| 2016-09-30 | -45.38% |
| 2016-06-30 | -68.15% |
| 2016-03-31 | -66.24% |
| 2015-12-31 | -61.52% |
| 2015-09-30 | -65.49% |
| 2015-06-30 | -66.44% |
| 2015-03-31 | -68.73% |
| 2015-01-31 | -54.63% |
| 2014-09-30 | -69.36% |
| 2014-06-30 | -72.89% |
| 2014-03-31 | -27.09% |
| 2013-12-31 | -21.17% |
| 2013-09-30 | -14.28% |
| 2013-06-30 | -12.12% |
| 2013-03-31 | -0.33% |
| 2012-12-31 | -24.98% |
| 2012-09-30 | -20.95% |
| 2012-06-30 | -45.46% |
| 2012-03-31 | -35.52% |
| 2011-12-31 | -50.79% |
| 2011-09-30 | -66.90% |
| 2011-06-30 | -70.11% |
| 2011-03-31 | -103.16% |
| 2010-12-31 | -81.71% |
| 2010-09-30 | -83.20% |
| 2010-06-30 | -114.83% |
| 2010-03-31 | -103.68% |
| 2009-12-31 | -73.91% |
| 2009-09-30 | -125.76% |
| 2009-06-30 | -366.30% |
| 2009-03-31 | -222.63% |
| 2008-12-31 | -0.06% |
| 2008-09-30 | -215.29% |
| 2008-06-30 | -238.34% |
| 2008-03-31 | -203.23% |
| 2007-12-31 | -0.08% |
| 2007-09-30 | -316.73% |
| 2007-06-30 | -369.86% |
| 2007-03-31 | -285.09% |
| 2006-12-31 | -0.01% |
| 2006-09-30 | -320.23% |
| 2006-06-30 | -313.03% |
| 2006-03-31 | -143.50% |
| 2005-12-31 | -85.22% |
| 2005-09-30 | -97.81% |
| 2005-06-30 | -96.03% |
| 2005-03-31 | -135.99% |
| 2004-12-31 | -62.96% |
| 2004-09-30 | -96.97% |
| 2004-06-30 | -159.66% |
| 2004-03-31 | -157.08% |
| 2003-12-31 | 120.03% |
| 2003-09-30 | -326.07% |
| 2003-06-30 | -438.49% |
| 2003-03-31 | -146.08% |
| 2002-12-31 | -87.56% |
| 2002-09-30 | -219.56% |
